You are here:Home-Chemical Inhibitors & Agonists-Tyrosine Kinase-FLT3-HM43239
HM43239

Chemical Structure : HM43239

CAS No.: 2569527-64-4

HM43239 (Tuspetinib, HM 43239)

Catalog No.: PC-20025Not For Human Use, Lab Use Only.

HM43239 (Tuspetinib, HM-43239) is a highly potent, selective FLT3 kinase inhibitor with IC50 of 1.1 nM, 1.8 nM and 1.0 nM aginst FLT3 WT, FLT3 ITD and FLT3 D835Y kinases, respectively.

Packing Price Stock Quantity
5 mg $98 In stock
10 mg $158 In stock
25 mg $278 In stock
50 mg $488 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

HM43239 (Tuspetinib, HM-43239) is a highly potent, selective FLT3 kinase inhibitor with IC50 of 1.1 nM, 1.8 nM and 1.0 nM aginst FLT3 WT, FLT3 ITD and FLT3 D835Y kinases, respectively.
HM43239 showed high selectivity toward FLT3 and AML associated other kinases (e.g. SYK, JAK and TAK1) in 191 kinases biochemically assays.
HM43239 potently inhibited the growth of AML cell lines harboring FLT3 ITD mutation, such as MV4-11 (IC50: 1.3 nM), MOLM-13 (5.1 nM) and MOLM-14 (2.9 nM).
HM43239 effectively inhibited the phosphorylation levels of FLT3 and of downstream kinases related with cell proliferation, induced caspase 3/7-dependent apoptosis in AML cell lines expressing FLT3 ITD mutant.
HM43239 inhibited proliferation and induced apoptosis of leukemic stem cell (LSC) marker-expressing KG1a cells (CD34+/CD38- cells) suggesting that the possibility for targeting LSC.
HM43239 showed the excellent dose proportional antitumor activity in mouse models xenografted with both MV4-11 and MOLM-13 cell line without any significant toxicity.

Physicochemical Properties

M.Wt 501.08
Formula C29H33ClN6
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

5-chloro-N-[3-cyclopropyl-5-[[(3R,5S)-3,5-dimethylpiperazin-1-yl]methyl]phenyl]-4-(6-methyl-1H-indol-3-yl)pyrimidin-2-amine

References

1. Miyoung Lee, et.al. Cancer Res July 1 2018 (78) (13 Supplement) 804.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: